The Food and Drug Administration is in the process of making a final decision about the proposed cap on sun protection factors (SPF). The American Academy of Dermatology continues to argue that capping sunscreens should be avoided, because clients apply a lower concentration than what is used in testing, and sunscreens that prevent UV-induced erythema do not prevent other harmful effects of ultraviolet radiation.